Charles Schwab
SPPI

Charles Schwab’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Charles Schwab’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-82,687
Closed -$79.4K – 3696
2023
Q2 		$79.4K Hold
82,687
– – ﹤0.01% 3365
2023
Q1 		$62K Hold
82,687
– – ﹤0.01% 3310
2022
Q4 		$30.5K Hold
82,687
– – ﹤0.01% 3454
2022
Q3 		$36K Buy
+82,687
New +$81.2K ﹤0.01% 3408
2022
Q2 		– Sell
-432,628
Closed -$559K – 3688
2022
Q1 		$559K Buy
432,628
+22,726
+6% +$20.9K ﹤0.01% 3067
2021
Q4 		$521K Buy
409,902
+177
+0% +$316 ﹤0.01% 3128
2021
Q3 		$893K Sell
409,725
-685,864
-63% -$1.87M ﹤0.01% 2917
2021
Q2 		$4.11M Buy
1,095,589
+107,218
+11% +$373K ﹤0.01% 2441
2021
Q1 		$3.22M Buy
988,371
+18,249
+2% +$65.4K ﹤0.01% 2506
2020
Q4 		$3.31M Buy
970,122
+5,139
+0.5% +$21.1K ﹤0.01% 2419
2020
Q3 		$3.94M Buy
964,983
+208,365
+28% +$792K ﹤0.01% 2194
2020
Q2 		$2.56M Buy
756,618
+60,621
+9% +$177K ﹤0.01% 2336
2020
Q1 		$1.62M Buy
695,997
+6,363
+0.9% +$17.4K ﹤0.01% 2348
2019
Q4 		$2.51M Buy
689,634
+14,458
+2% +$117K ﹤0.01% 2351
2019
Q3 		$5.6M Buy
675,176
+39,003
+6% +$316K ﹤0.01% 1910
2019
Q2 		$5.48M Buy
636,173
+37,173
+6% +$333K ﹤0.01% 1931
2019
Q1 		$6.4M Buy
599,000
+41,986
+8% +$450K ﹤0.01% 1855
2018
Q4 		$4.87M Sell
557,014
-42,544
-7% -$542K ﹤0.01% 1915
2018
Q3 		$10.1M Buy
599,558
+34,079
+6% +$737K 0.01% 1634
2018
Q2 		$11.9M Buy
565,479
+87,075
+18% +$1.61M 0.01% 1476
2018
Q1 		$7.7M Buy
478,404
+19,954
+4% +$395K 0.01% 1677
2017
Q4 		$8.69M Sell
458,450
-47,459
-9% -$860K 0.01% 1578
2017
Q3 		$7.12M Buy
505,909
+70,487
+16% +$638K 0.01% 1687
2017
Q2 		$3.24M Sell
435,422
-110,588
-20% -$723K ﹤0.01% 2027
2017
Q1 		$3.55M Sell
546,010
-555,398
-50% -$3.11M ﹤0.01% 1950
2016
Q4 		$4.88M Sell
1,101,408
-80,690
-7% -$338K 0.01% 1753
2016
Q3 		$5.52M Buy
1,182,098
+209,210
+22% +$1.24M 0.01% 1584
2016
Q2 		$6.39M Buy
972,888
+67,894
+8% +$480K 0.01% 1397
2016
Q1 		$5.76M Sell
904,994
-20,038
-2% -$103K 0.01% 1426
2015
Q4 		$5.58M Sell
925,032
-4,747
-0.5% -$27.1K 0.01% 1446
2015
Q3 		$5.56M Buy
929,779
+41,885
+5% +$291K 0.01% 1398
2015
Q2 		$6.07M Buy
887,894
+4,592
+0.5% +$29.2K 0.01% 1425
2015
Q1 		$5.36M Buy
883,302
+87,296
+11% +$581K 0.01% 1469
2014
Q4 		$5.52M Buy
796,006
+262,574
+49% +$1.93M 0.01% 1369
2014
Q3 		$4.34M Buy
533,432
+283,288
+113% +$2.22M 0.01% 1492
2014
Q2 		$2.03M Buy
250,144
+94,086
+60% +$714K ﹤0.01% 1975
2014
Q1 		$1.22M Buy
156,058
+3,240
+2% +$27.4K ﹤0.01% 2185
2013
Q4 		$1.35M Buy
152,818
+3,888
+3% +$34.7K ﹤0.01% 2125
2013
Q3 		$1.25M Buy
148,930
+16,470
+12% +$133K ﹤0.01% 2108
2013
Q2 		$1.04M Buy
+132,460
New +$1.02M ﹤0.01% 2144

Charles Schwab's SPPI Position: Q3 2023 in Review

Charles Schwab sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 82,687 shares — an estimated $79.4K sold.

Charles Schwab first reported a position in SPPI in Q2 2013 and held it in 40 quarters. The position peaked at $11.9M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Charles Schwab reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 82,687 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $79.4K.
  • Charles Schwab first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 40 quarters.
  • Charles Schwab's Spectrum Pharmaceuticals Inc position peaked at $11.9M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.